Respiratory Syncytial Virus-associated hospitalization in premature infants who did not receive palivizumab prophylaxis in Italy: a retrospective analysis from the Osservatorio Study

BACKGROUND: Due to different social and epidemiological factors, the eligibility criteria to receive palivizumab prophylaxis may be different between countries, especially in “otherwise healthy” late preterm infants. METHODS: We analyzed an Italian database of young children referred to emergency de...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ital J Pediatr
Main Authors: Silvestri, Michela, Marando, Francesca, Costanzo, Anna Maria, di Luzio Paparatti, Umberto, Rossi, Giovanni A.
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4845497/
https://ncbi.nlm.nih.gov/pubmed/27112952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-016-0252-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares